Safety and Efficacy Study of Epitope Peptide To Treat HLA-A*24 Disease Controlled Advanced Non-small Cell Lung Cancer

by lowes1 on September 25, 2013

Condition:   Non-small Cell Lung Cancer
Intervention:   Biological: HLA-A*2402restricted URLC10, CDCA1, and KIF20A peptides with adjuvant
Sponsors:   Shiga University;   Shiga University;   Tokyo University
Recruiting – verified September 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: